Vicore Pharma’s C21 med shows promise in COVID-19 study
admin 23rd December 2020 Uncategorised 0Drug is being studied in hospitalised COVID-19 patients More: Vicore Pharma’s C21 med shows promise in COVID-19 study Source: News
read more
Drug is being studied in hospitalised COVID-19 patients More: Vicore Pharma’s C21 med shows promise in COVID-19 study Source: News
read moreOral solution approved to treat seizures associated with Dravet syndrome More: EU green light for Zogenix’s Fintepla Source: News
read morePayment for drug linked to value to NHS rather than volume used More: Shionogi’s novel antibiotic added to UK’s pilot subscription reimbursement model Source: News
read moreFierce Pharma’s top 2020 marketing stories pack pandemic punch to digital, reputation and drug launches bbulik Tue, 12/22/2020 – 17:19 More: Fierce Pharma's top 2020 marketing stories pack pandemic punch to digital, reputation and drug launches Source: fierce
read morePharma’s edition of the 2020 story, as told by Fierce readers tstaton Tue, 12/22/2020 – 15:09 More: Pharma's edition of the 2020 story, as told by Fierce readers Source: fierce
read morePfizer, Moderna urge calm as they launch tests of vaccines against mutated COVID-19 arlene.weintraub Tue, 12/22/2020 – 09:42 More: Pfizer, Moderna urge calm as they launch tests of vaccines against mutated COVID-19 Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals